Literature DB >> 11739501

IL-2, -4, and -15 differentially regulate O-glycan branching and P-selectin ligand formation in activated CD8 T cells.

D A Carlow1, S Y Corbel, M J Williams, H J Ziltener.   

Abstract

The glycosyltransferase core 2 beta1-6 N-acetylglucosaminyl transferase (C2GnT1 or C2GlcNAcT1) is responsible for formation of branched structures on O-glycans present on cell surface glycoproteins. The O-glycan branch created by C2GnT1 is physiologically important insofar as only this structure can be extended and modified to yield P-selectin ligands that promote initial interactions between extravasating lymphocytes and endothelia. In mature T cells, C2GnT1 activity is thought to be induced as an intrinsic consequence of T cell activation. Through analysis of C2GnT1-dependent epitopes on CD43 and CD45RB we have found that in activated CD8(+) T cells expression of C2GnT1 was dependent upon exposure to specific cytokines rather than being induced as a direct consequence of activation. Activated CD8(+) cells became receptive to strong induction of C2GnT1 expression and P-selectin ligand expression in response to IL-2, moderate induction by IL-15, and minimal induction in response to IL-4. Our observations clarify the relationship between T cell activation and C2GnT1 expression, demonstrate the differential impact of distinct cytokines on expression of C2GnT1 activity and P-selectin ligand, and reinforce the concept that the cytokine milieu subsequent to activation can influence adhesion systems that dictate lymphocyte homing properties.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739501     DOI: 10.4049/jimmunol.167.12.6841

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10.

Authors:  Jay S Fine; Alberto Rojas-Triana; James V Jackson; Laura W Engstrom; Gregory S Deno; Daniel J Lundell; Loretta A Bober
Journal:  Inflammation       Date:  2003-08       Impact factor: 4.092

2.  Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration.

Authors:  Isabel Correa; Tim Plunkett; Anda Vlad; Arron Mungul; Jessica Candelora-Kettel; Joy M Burchell; Joyce Taylor-Papadimitriou; Olivera J Finn
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

3.  Enzymatic synthesis of core 2 O-glycans governs the tissue-trafficking potential of memory CD8+ T cells.

Authors:  Jossef F Osborn; Jana L Mooster; Samuel J Hobbs; Michael W Munks; Conrad Barry; John T Harty; Ann B Hill; Jeffrey C Nolz
Journal:  Sci Immunol       Date:  2017-10-13

Review 4.  Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration.

Authors:  Robert Sackstein
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

5.  Control of core 2 beta1,6 N-acetylglucosaminyltransferase-I transcription by Sp1 in lymphocytes and epithelial cells.

Authors:  V Rebecca Falkenberg; Nevis Fregien
Journal:  Glycoconj J       Date:  2007-05-26       Impact factor: 2.916

6.  Effector and Regulatory T Cells Roll at High Shear Stress by Inducible Tether and Sling Formation.

Authors:  Michael Abadier; Akula Bala Pramod; Sara McArdle; Alex Marki; Zhichao Fan; Edgar Gutierrez; Alex Groisman; Klaus Ley
Journal:  Cell Rep       Date:  2017-12-26       Impact factor: 9.423

Review 7.  T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.

Authors:  Robert Sackstein; Tobias Schatton; Steven R Barthel
Journal:  Lab Invest       Date:  2017-03-27       Impact factor: 5.662

Review 8.  Regulation of T Cell Trafficking by Enzymatic Synthesis of O-Glycans.

Authors:  Samuel J Hobbs; Jeffrey C Nolz
Journal:  Front Immunol       Date:  2017-05-24       Impact factor: 7.561

9.  Requirement for core 2 O-glycans for optimal resistance to helminth infection.

Authors:  Sarah C Mullaly; Menno J Oudhoff; Paul H Min; Kyle Burrows; Frann Antignano; David G Rattray; Alistair Chenery; Kelly M McNagny; Hermann J Ziltener; Colby Zaph
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.